Skip to main content

Table 1 Patients providing tissue

From: Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension

  Patient type Sex Age Mean PA pressure (mmHg) Medications PVR (dyne*sec)/cm5 Lung tissue
1 Control (Benign tumor) F 35 ND None ND Yes
2 Control (Lung Cancer) F 38 ND None ND Yes
3 Control (Benign tumor) M 45 ND None ND Yes
4 Control (Lung Cancer) M 51 ND None ND Yes
5 Control (Hodgkin) M 48 ND None ND Yes
6 Control (Benign tumor) F 44 ND None ND Yes
7 Control (Lung Cancer) F 47 ND None ND Yes
8 Control (Lung Cancer) F 50 ND None ND Yes
9 iPAH F 58 56 Epoprostenol/Lasix/Coumadin 1709 Yes
10 iPAH F 36 67 Epoprostenol/Lasix/Coumadin 2274 Yes
11 SSC-PAH F 55 48 Epoprostenol/Lasix/Coumadin 980 Yes
12 PAH group1 F 64 59 Bosentan/Lasix 926 Yes
13 PAH group1 M 72 39 Lasix/Sitaxsentan 550 Yes
14 PAH group1 M 58 42 Epoprostenol/Lasix/Coumadin 991 Yes
15 PAH group1 F 51 51 Lasix/coumadin 1199 Yes
16 PAH group1 F 48 73 Epoprostenol/Lasix 1800 Yes
17 PAH group1 F 51 41 Lasix 990 Yes
18 PAH group1 F 68 37 Lasix/coumadin/Norvasc 544 Yes